We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BIOCAD

News List

BIOCAD, SPH to build drug substance manufacturing facility in China biospectrumasia
September 17, 2018
These Russian-Chinese joint ventures will be established with the main purpose of development, manufacturing, authorization, and marketing of at least six BIOCAD products.
BIOCAD enters the European market worldpharmanews
October 26, 2017
The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines.
BIOCAD does its sums for growth europeanpharmaceuticalreview
July 31, 2017
Russian biotech company BIOCAD plans to leverage competitive advantages to take 5% of the European medicines market